stockportfolio.pro
Stocks / MIRM vs RYTM
MIRM vs RYTM
Mirum Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Mirum Pharmaceuticals, Inc. (MIRM) | Rhythm Pharmaceuticals, Inc. (RYTM) | |
|---|---|---|
| Market cap | $6.0B | $5.9B |
| Revenue (latest FY) | $521.31M | $189.76M |
| Net income (latest FY) | $-23.36M | $-196.54M |
| Revenue growth (5y CAGR) | — | — |
| Net margin | -4.5% | -103.6% |
| Return on equity | -7.4% | -72.8% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open MIRM — free Open RYTM — freeFrequently asked questions
Which is bigger, MIRM or RYTM?
Mirum Pharmaceuticals, Inc. is larger by market capitalization — $6.0B versus $5.9B.
Which grows faster, MIRM or RYTM?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.